Fig. 6From: Early Treatment Uptake and Cost Burden of Hepatitis C Therapies Among Newly Diagnosed Hepatitis C Patients with a Particular Focus on HIV CoinfectionChoice of agents among patients who initiated all-oral therapies during the post-DAA period (n = 4775)Back to article page